USE OF RECOMBINANT ALFA-2B INTERFERON IN A CHRONIC HEPATITIS-C CONTROLLED TRIAL

被引：0
|
作者：
ARUS, E [1 ]
INFANTE, M [1 ]
PADRON, G [1 ]
FERNANDEZ, A [1 ]
ROCA, J [1 ]
MORALES, M [1 ]
GRA, B [1 ]
机构：
[1] HOSP LUIS DIAZ SOTO,CTR GENET ENGN & BIOTECHNOL,INST GASTROENTEROL,HAVANA,CUBA
来源：
HEPATOLOGY | 1994年 / 19卷 / 04期
关键词：
D O I：
10.1016/0270-9139(94)90328-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：I40 / I40
页数：1
相关论文
共 50 条
  • [21] EFFECT OF INTERFERON ALFA-2B THERAPY FOR HEPATITIS-C ON HISTOLOGY AND LIDOCAINE METABOLISM
    WATERS, B
    PORTERA, FA
    SMALLEY, DL
    ADAMEC, TA
    PRASAD, S
    KARAS, JG
    STENTZ, FB
    RIELY, CA
    HEPATOLOGY, 1992, 16 (04) : A272 - A272
  • [22] Induction of Autoimmune Hepatitis by Pegylated Interferon Alfa-2b in Chronic Hepatitis C
    Loerke, Julia
    Erhardt, Andreas
    Haeussinger, Dieter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (12) : A20 - A20
  • [23] Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C
    Kraus, Michael R.
    Schaefer, Arne
    Csef, Herbert
    Scheurlen, Michael
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (12) : 1769 - 1774
  • [24] Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C
    Michael R Kraus
    Arne Sch(a|¨)fer
    Herbert Csef
    Michael Scheurlen
    World Journal of Gastroenterology, 2005, (12) : 1769 - 1774
  • [25] Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C
    Schaefer, A
    Scheurlen, M
    Csef, H
    Kraus, MR
    GASTROENTEROLOGY, 2004, 126 (04) : A695 - A695
  • [26] Hepatitis C in adults and adolescents with hemophilia: A randomized, controlled trial of interferon alfa-2b and ribavirin
    Fried, MW
    Peter, J
    Hoots, K
    Gaglio, PJ
    Talbut, D
    Davis, PC
    Key, NS
    White, GC
    Lindblad, L
    Rickles, FR
    Abshire, TC
    HEPATOLOGY, 2002, 36 (04) : 967 - 972
  • [27] RESPONSE RELATED FACTORS IN RECOMBINANT INTERFERON-ALFA-2B TREATMENT OF CHRONIC HEPATITIS-C
    PEREZ, R
    PRAVIA, R
    LINARES, A
    RODRIGUEZ, M
    LOMBRANA, JLS
    SUAREZ, A
    RIESTRA, S
    NAVASCUES, CA
    RODRIGO, L
    GUT, 1993, 34 (02) : S139 - S140
  • [28] Comparative efficacy of high and low dose of interferon alfa-2b in chronic hepatitis C: A randomized controlled trial.
    Tassopoulos, NC
    Karvountzis, G
    Touloumi, G
    Delladetsima, J
    Papatheodoridis, GV
    Katsoulidou, A
    Retalis, G
    Hatzakis, A
    HEPATOLOGY, 1996, 23 (01) : T67 - T67
  • [29] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
    Manns, MP
    McHutchison, JG
    Gordon, SC
    Rustgi, VK
    Shiffman, M
    Reindollar, R
    Goodman, ZD
    Koury, K
    Ling, MH
    Albrecht, JK
    LANCET, 2001, 358 (9286): : 958 - 965
  • [30] A RANDOMIZED, CONTROLLED TRIAL OF INTERFERON ALFA-2B ALONE AND WITH SIMULTANEOUS PREDNISONE FOR THE TREATMENT OF CHRONIC HEPATITIS-B
    ZARSKI, JP
    CAUSSE, X
    COHARD, M
    COUGNARD, J
    TREPO, C
    ABERGEL, A
    ANDREANI, T
    AUCOUTURIER, JP
    BAESJOU, S
    BERNARD, PA
    BORG, R
    BRESSONHADNI, S
    BUFFET, C
    DESMORAT, H
    DUFFAUT, M
    KLOTZ, F
    LEVY, VG
    MOREAU, J
    PETIT, R
    CALES, P
    POL, S
    BERTHELOT, P
    POYNARD, T
    RINALDI, Y
    TRAN, A
    VALLA, D
    VETTER, D
    JOURNAL OF HEPATOLOGY, 1994, 20 (06) : 735 - 741
12345